Fig. 9From: The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to deathThe EP2 agonist butaprost (But) protects OPCs from KA-induced toxicity. OPC survival was assessed 48 h following treatment of OPCs with KA in the presence or absence of butaprost (500 nM). This graph represents the combined data from four independent experiments. Significant protection (Student t-test) was observed for ButaprostBack to article page